Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Gulf War Illness
NCT04712071Phase 1Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in Gulf War syndrome (GWS), sponsored by Baylor College of Medicine. Primary endpoint: Change in 40Hz Auditory steady state response (ASSR) EEG power at 95 months. Started Feb 2021; status: terminated.
02
Drugs
ketamine
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT04712071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712071.